SEMA3C and prostate cancer: Here, we demonstrate that SEMA3C, an autocrine prostate cancer growth factor, can induce the expression of key steroidogenic enzymes while simultaneously suppressing the expression of androgen-inactivating enzymes leading to increased synthesis of androgens such as testosterone and DHT from adrenal hormones such as DHEA or de novo from cholesterol.